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A B S T R A C T
Background: The objectives of this study were to analyze the impact of infections on prolonging hospital
stay with consideration of underlying risk factors and determining the mortality rates and its association
with infections.
Methods: An electronic database developed from a continuous prospective targeted infection
surveillance program was used in the study. Data were collected from 2009 to 2012 in five Polish
tertiary academic neonatal intensive care units (NICUs). The length of stay (LOS) of 2,003 very low birth
weight (VLBW) neonates was calculated as the sum of the number of days since birth until death or until
reaching a weight of 1,800 g.
Results: The median LOS for neonates with infections was twice as high as for neonates without
infection. LOS was significantly affected by the overall general condition of the neonate, as expressed by
both gestational age and birth weight as well as by the Clinical Risk Index for Babies (CRIB) score; another
independent factor was presence of at least one infection. Risk of in-hospital mortality was significantly
increased by male sex and vaginal birth and was lower among breastfed neonates. Deaths were
significantly more frequent in neonates without infection.
Conclusions: The general condition of VLBW infants statistically increase both their risk of mortality and
LOS; this is in contrast to the presence of infection, which significantly prolonged LOS only.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Nosocomial infections are one of the most frequent adverse
events among hospitalized patients and are a threat to all patients.
However, in some patient populations (e.g., those undergoing
surgical procedures and in intensive care units [ICUs]), the risk of
acquiring a nosocomial infection is particularly high. Among
infants hospitalized in ICUs, and especially those of very low birth
weight (VLBW), there is a greater risk of acquiring an infection. The* Corresponding author. Chair of Microbiology, Jagiellonian University Medical
College, 18 Czysta Street, 31-121 Krakow, Poland. Tel.: +4812 633 00 60;
fax: +4812 423 39 24.
E-mail address: rozanska@ifb.pl (A. Różańska).
http://dx.doi.org/10.1016/j.ijid.2015.04.017
1201-9712/ 2015 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).increased risk of infection in this neonatal population is associated
with a lower gestational age (as extremely premature infants have
thinner, more permeable skin, underdeveloped innate and
adaptive immune responses, and immature mucous membranes)
and their underlying illness,1,2 as well as the requirements for
invasive therapies, such as central venous intravenous catheters,
and the hygiene practices of health care providers.
The most frequent infections in neonatal intensive care units
(NICUs) are bloodstream infections, pneumonia, and necrotising
enterocolitis (NEC); less frequent complications are infections of
the urinary tract and the central nervous system.3,4 Infections
among VLBW infants may, directly or indirectly, result in the death
of an infant; however, even with effective treatment, infections in
this population may be associated with a prolonged length of stay
(LOS).ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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determined a 19.7% incidence of central line-associated blood-
stream infections (CLABSIs), which were associated with an
increase in the marginal cost of hospitalization for a single
neonate from $5,875 to $12,480. Rates of ventilator-associated
pneumonia (VAP) in the NICU were reported in the range of 0.2 to
1.6 per 1000 person-days of ventilation, according to 2011 data
reported in National Healthcare Safety Network (NHSN) in the
United States.3 According to the NHSN, VAP in NICUs accounted for
approximately one-fifth of all infections, and CLABSIs for nearly
80%. In a study by Rosenthal et al., crude rates for excess mortality
associated with CLABSIs and VAP were determined to be 27.7% and
17.9%, respectively.5
The objectives of the present study were to determine:
1) the association between the presence of infections in VLBW
neonates and the LOS for neonates surviving until they reach a
weight of 1,800 grams;
2) the association between the presence of infections and in-
hospital mortality; and
3) if infection is an independent risk factor for the above
mentioned outcomes, with consideration of other risk factors
unrelated to infection,
2. Materials and methods
An electronic database, created as a result of continuous
prospective surveillance of infections, that focused on VLBW
neonates was used in the study. Data were collected between
January 1, 2009 and December 31, 2013 at five tertiary academic
NICUs that took part in the Polish Neonatology Surveillance
Network (PNSN). The PNSN is a prospective national surveillance
system for the most relevant infections in VLBW infants (birth
weight <1,500 g) in Poland. These urban tertiary teaching hospital
NICUs provide care for 20% of all VLBW infants born in Poland
annually. Details of the following variables were collected for all
VLBW infants: birth weight and gestational age, gender, multiple
pregnancy, type of delivery, information on the situation at the
time of delivery (e.g., chorioamnionitis), general physical state as
measured by Apgar scores at 1 and 5 minutes and the Critical Risk
Index for Babies (CRIB) score, and detailed data on antibiotic
treatment. The PNSN recorded severe infections, including
bloodstream infections (CLA-BSI and other cases of BSI) and
pneumonia (PNEU), observed during hospitalization (from admis-
sion to discharge, transfer, or death). NICU participation in the
PNSN was voluntary and confidential.
Utilisation of data collected by the PNSN for scientific purposes
was approved by the Bioethics Committee of Jagiellonian
University Medical College (no. KBET/221/B/2011). All data
entered into the electronic database and analysed during the
compilation of this article were previously de-identified. Data
were obtained during routine treatment and diagnostic proce-
dures performed during patients’ hospitalisation. Before analysis,
incomplete records (without date of birth/discharged/death;
gender; data about infections) were deleted and, as a result,
complete records of 1,038 neonates without infections and
965 neonates with BSIs, PNEU, or other types of infection were
available.
Neonates with birth weight less than 1,500 g (considered as
VLBW) were included in the study. Cases of early and/or late
infections (BSI, PNEU, NEC) in neonates (only with clinical signs
of infection) were defined according to Gastmeier et al.6, with
some modification. Standard indicators of the general state of
neonates were Apgar scores (at 1 and 5 minutes) and CRIB scores.
Diagnosis of chorioamnionitis was based on clinical evaluationwithout the need for microbiological or histopathological
examination.7 Determination of the microbial species and
evaluation of drug resistance were conducted by local microbio-
logic laboratories.
The device utilization rate (calculated by dividing the number
of device days by the total number of patient days) was 0.45 for
central venous catheters (CVCs), 0.16 for peripheral intravenous
catheters (PVCs), 0.25 for mechanical ventilation (MV), and 0.18 for
continuous positive airway pressure (CPAP). LOS for neonates in
the NICU was calculated as the sum of the number of days since
birth until death or discharge from the hospital. In three of the five
participating NICUs, this occurred at reaching 34 to 35 weeks of
gestational age and in two, on reaching a weight of 1,800 g.
Data were analysed in two ways. The relationship between
particular clinical effects and single elements of care procedures
were investigated with univariate statistics. The selection of
statistical techniques depended on the type and distribution of the
variables analysed. If both dependent and independent variables
were categorical, qualitative frequency tests such as chi square or
likelihood ratio were used. If the dependent variable was
continuous (e.g., LOS or birth weight) and the predictors were
qualitative, the Mann-Whitney U test for dichotomous predictors
or Kruskal-Wallis test were calculated. More powerful parametric
tests (e.g., analysis of variance or student t-test) could not be used
because of non-normal distribution of the dependent variables.
Common effects of several variables on mortality probability were
analysed with a generalized linear model. Because of the
dichotomous character of the effect and different types of
predictors, a model was constructed with an assumption of a
binominal distribution of the dependent variable and logit-linked
function. The assumed critical value of the significance level was
p < 0.05.
3. Results
The PSNS included 2,003 VLBW neonates, including 372
extremely low birth weight infants (18.6%) with a birth weight
up to 750 g, 516 infants (25.8%) with birth weight ranging from
751 to 999 g, and 1,115 infants (55.7%) with birth weight ranging
from 1,000 to 1,500 g (Table 1).
3.1. Risk of infection
The risk of infection significantly correlated with birth weight;
the strongest correlation was found in neonates with birth weights
ranging from 750 to 999 g (Table 1). Also, delivery at 28 weeks
gestation or earlier was associated with a 3.5-fold higher risk of
infection as compared to VLBW neonates born at 28 weeks
gestation or later. Significance of the correlation between infection
and interventions such as CVC, MV, and CPAP, and medians days of
use of these interventions was determined; risk of infection in
neonates with exposure to these interventions was five to ten
times higher compared to no exposure (Table 1). Neonates with
infections were treated with antimicrobial agents for a mean of
19 days.
3.2. In-hospital mortality
Median birth weight and gestational age of neonates who died
were significantly lower, similar to general neonate condition
expressed by Apgar scores at 1 and 5 minutes. The highest
mortality rate was found in neonates with birth weight less than
750 g (50.5%) and/or delivered in the 28th week of gestation or
later (30.1%). However, risk of in-hospital mortality was signifi-
cantly increased by male sex and vaginal birth. The risk of
Table 1
Baseline characteristics of VLBW newborns with and without infections
Baseline characteristics Infants with infections N = 965 Infants without infections N = 1038 OR (95%CI) p
median birth weight (grams) (IQR) 960 (770 – 1200) 1150 (890 – 1340) NA <0.001
<750 grams n (%) 208 (21.6) 164 (15.8) 1.46 (1.167-1.837) <0.001
750-999 grams n (%) 326 (33.8) 190 (18.3) 2.28 (1.853-2.799) <0.001
1000-1249 grams n (%) 241(25.0) 281 (27.1) 0.897 (0.734-1.095) <0.001
1250-1499 grams n (/%) 190 (18.5) 403 (38.0) 0.39 (0.316-0.473) <0.001
median gestational age / (IQR) 28.0 (26 – 30) 29.0 (27 – 31) NA <0.001
less than or equal to 28 weeks n (%) 626 (64.87) 355 (34.20) 3.55 (2.955- 4.271) <0.001
more than 28 weeks n (%) 339 (35.13) 683 (65.80) <0.001
female sex n (%) 442 (46.53) 508 (53.47) 0.88 (0.7397 – 1.051) -
male sex n (%) 523 (49.67) 530 (50.33) -
CC n (%) 766 (47.25) 855 (52.75) 0.82 (0.658 – 1.030) -
vaginal birth n (%) 198 (52.11) 182 (47.89) -
breastfeeding n (%) 79 (42.02) 106 (56.38) 0.78 (0.578 – 1.064) 0.019
CVC [days] median (IQR) 11 (0 – 24) 1 (0 – 8) NA <0.001
MV [days] median (IQR) 5 (0 – 19) 1 (0 – 20 NA <0.001
CPAP [days] median (IQR) 8 (2 – 18) 0 (0 – 3) NA <0.001
antibiotics [days] median (IQR) 19 (13-29) 4 (1 – 7) NA <0.001
CRIB median (IQR) 4 (1 – 7) 2 (1 – 7) NA -
Apgar 1 median (IQR) 6 (4 – 7) 6 (4 – 7) NA <0.001
Apgar 5 median (IQR) 6 (5 – 7) 7 (5 – 8) NA <0.001
chorioamnionitis n (%) 76 (53.15) 67 (46.85) 1.24 (0.881-1.742) -
PROM n (%) 268 (56.07) 210 (43.93) 1.52 (1.233-1.864) <0.001
multiple birth n (%) 221 (42.26) 302 (57.74) 0.72 (0.592-0.885) 0.002
Outcomes
LOS [days] median /(IQR) 44 (29 – 58) 22 (1 – 13) NA <0.001
Discharge n (%) 779 (56.65) 596 (43.35) 3.106 (2.538-3.801) <0.001
Transfer n (%) 101 (33.33) 202 (66.67) 0.49 (0.374-0.626) <0.001
Died n (%) 85 (26.23) 239 (73.77) 0.32(0.247-0.421) <0.001
IQR - Interquartile Range; OR odds ratio; 95% CI 95% confidence interval; NA not available.
CC Caesarean section; CPAP continuous positive airway pressure; CRIB Critical Risk Index for Babies; CVC central venous catheter; LOS length of stay; MV mechanical
ventilation; PROM premature rupture of membranes; VLBW very low birth weight.
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strong trend (p = 0.019; OR 0.78; 95% CI 0.578-1.064) – Table 1.
Invasive procedures (CVC, PVC, MV, CPAP) were used for a
longer period of time in the neonates who survived to hospital
discharge in comparison with neonates who did not survive
(Table 2). Neonatal deaths were significantly more frequent among
neonates without infection (Table 1), and, at the same time, the
average LOS was 19 times shorter (because of early deaths)
compared to surviving neonates who were discharged from the
NICU (Table 2).
3.3. Length of hospital stay
The median LOS for all neonates with infections was twice as
high as for neonates without infection (44 days vs. 22 days) –
Table 1. However, taking into consideration only neonates who
were discharged from the NICU as a result of achieving their
expected birth weight (i.e., a successful treatment), the median
stay for neonates without infection was longer - 30 days, compared
with a median stay of 45 days for neonates with at least one type of
infection – Table 2. Moreover, specific infections or multiple
infections in a neonate affected LOS to varying degrees. The
occurrence of more than two types of infection resulted in a two-
fold prolongation of LOS for neonates in the NICU (60 days vs.
30 days without infections); PNEU and BSI were associated with a
longer LOS, by approximately 20 days (Table 2).
3.4. Independent predictor of length of stay by multivariate analysis
The LOS in the NICU was significantly affected by the general
overall condition of the neonate, expressed by both gestational
weight and gestational age as well as CRIB scores. The other
independent factor was the presence of at least one infection.4. Discussion
Infections in neonates, particularly those with the lowest
weight, remain one of the most important problems in modern
medicine. One issue is an increasing number of premature births,
as well as the increase in multiple pregnancies.8,9 Another cause
might be the improvement in the survival rate of VLBW neonates in
modern NICUs, which are better equipped for life-saving intensive
care nowadays than in the past.
Our results for mortality and LOS are the first to be reported by
the PNSN and from Central Europe based on a national program for
infection surveillance and control in NICUs. Our previous report on
this population within the PNSN focused on various types of
infection or their aetiology.10–13 In the study population, the
epidemiology and microbiology of infections did not differ from
data obtained in other multi-setting studies.14,15
It is thought that NICU admission and treatment may be
connected with a high incidence and mortality rates related to both
early- and late-onset infections.16–22 In Poland, in a studied group
of neonates with symptoms of early-onset infections (EOIs), an
increased case-fatality rate was not observed. Early mortality (i.e.,
<7 days after delivery) was 17% for early-onset BSI and 8% for
early-onset PNEU. The case-fatality rate associated with late-onset
BSI was 7.5%.10,11 However, our present results indicate that
infections are not a significant factor for increasing VLBW neonatal
mortality. The birth weight and gestational age proved to be more
important. Also, other authors have confirmed our observations.
Infants born at the threshold of viability (those with a gestational
age of 23 to 25 weeks, a birth weight <500 g, or both) are at the
greatest risk for a poor outcome. For example, in the Vermont
Oxford Network (a voluntary network for data collection from
more than 650 NICUs in the United States and worldwide), among
infants born between 1996 and 2000 with a birth weight of 401 to
Table 2
In-hospital mortality of VLBW neonates in the PNSN
Baseline characteristics Death in-hospital N = 324 Discharge N = 1375 OR (95%CI) p
median birth weight (grams) (IQR) 750 (600 – 1000) 1105 (900 – 1320) NA <0.001
<750 grams n (%) 157 (50.48) 154 (49.52) 7.45 (5.662 – 9.812) <0.001
750-999 grams n (%) 85 (20.00) 340 (80.00) 1.08 (0.821 – 1.427) <0.001
1000-1249 grams n (%) 48 (11.06) 386 (88.94) 0.45 (0.321 – 0.619) <0.001
1250-1499 grams n (/%) 34 (6.65) 495 (96.87) 0.21 (0.144 – 0.302) <0.001
median gestational age / (IQR) 26.0 (24 – 28) 29.0 (27 – 31) NA <0.001
less than or equal to 28 weeks n (%) 261 (30.10) 606 (69.90) 5.26 (3.914 – 7.061) <0.001
more than 28 weeks n (%) 63 (7.62) 764 (92.38) 0.19 (0.144 – 0.259) <0.001
female sex n (%) 132 (16.42) 672 (83.58) 0.72 (0.563 – 0.919) <0.001
male sex n (%) 192 (21.45) 703 (78.55)
CC n (%) 224 (16.37) 1144 (83.63) 0.45 (0.342 – 0.593) <0.001
vaginal birth n (%) 100 (30.30) 230 (69.70)
breast feeding n (%) 3 (1.73) 170 (98.27) 0.07 (0.021-0.209) <0.001
CVC [days] median (IQR) 1 (0 – 4) 7 (0 - 180 NA <0.001
MV [days] median (IQR) 2 (1 - 60 1 (0 – 8) NA <0.001
CPAP [days] median (IQR) 0 (0 – 0) 5 (1 – 14) NA <0.001
antibiotics [days] median (IQR) 2 (1 – 6) 13 (6 – 23) NA <0.001
CRIB median (IQR) 8 (6 - 120 2 (1 – 5) NA <0.001
Apgar 1 median (IQR) 3 (1 – 5) 6 (5 – 7) NA <0.001
Apgar 5 median (IQR) 4 (1 – 6) 7 (6 – 8) NA <0.001
chorioamnionitis n (%) 25 (20.490 97 (79.51) 1.10 (0.697-1.740) -
PROM n (%) 75 (18.07) 340 (81.93) 0.92 (0.689-1.220) -
multiple birth n (%) 87 (19.33) 363 (80.67) 1.02 (0.779-1.345) -
Outcomes: LOS (days)
median /(IQR) 2 (0 – 8) 38 (27 - 530 NA <0.001
No infection- median /(IQR) 0 (0 – 3) 30 (23 – 38) 3.68 (2.807-4.812) <0.001
At least 1 infection- median /(IQR) 12 (4 – 23) 45 (32 – 59) 0.27 (0.208-0.356) <0.001
BSI - median /(IQR) 12 (4 – 21) 48 (33 – 61) 0.38 (0.282-0.516) <0.001
PNEU - median /(IQR) 19 (9 – 26) 51 (39 – 65) 0.29 (0.203-0.425) <0.001
> one infection - median /(IQR) 26 (16 – 40) 60 (48 – 69) 0.32 (0.210-0.495) <0.001
IQR - Interquartile Range; OR odds ratio; 95% CI 95% confidence interval; NA not available.
BSI bloodstream infection; CC Caesarean section; CPAP continuous positive airway pressure; CRIB Critical Risk Index for Babies; CVC central venous catheter; LOS length of
stay; MV mechanical ventilation; PNEU pneumonia; PROM premature rupture of membranes; VLBW very low birth weight.
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was 83%.23 This is similar to the rate among surveyed Polish VLBW
neonates (75%).10 The risk of death decreases significantly with an
increase in birth weight.24 Overall, in the group of VLBW neonates,
general in-hospital mortality (not associated with infections) was
16.7% in Italy25 and 14.3% in Korea.26 In developing countries, in-
hospital mortality is higher; 28.1% in Iran27 and 35% in India.28
Unfortunately, the neonates in-hospital mortality may also depend
on other risk factors. In a study by Apisarnthanarak et al. regarding
VAP in extremely preterm neonates, the in-hospital mortality rate
was 27%. In such defined populations, VAP was the only significant
risk factor for mortality.29
In nearly half (48.2%) of all studied VLBW neonates, at least one
clinical infection developed during the time period studied. But it
was found that infection was not a factor affecting the risk of
neonatal death. Conversely, infections were observed mainly
among the neonates that survived. Infection was one of the
independent factors influencing the prolongation of the neonate’s
stay in the NICU. However, at the same time, the occurrence of one
or more clinical infections, as well as the site of infection, had a
variable effect on LOS. The occurrence of more than one infection
was associated with the longest LOS for neonates in the NICU; the
median LOS was 60 days versus 30 days for neonates without an
infection. Among neonates who developed one infection, PNEU
was associated with the highest median LOS as compared to
neonates without an infection (51 days vs. 30 days). This value is
only slightly higher than that for BSIs, where the median LOS was
48 days.
For studies regarding prolonged LOS by neonates in NICUs
conducted by other authors, results that differ from the data
presented in our work, were reviewed. Apisarnthanarak et al.29
observed a median LOS for neonates with VAP almost three times
higher than that for neonates in Polish NICUs (138 days [SD13-361] vs. 82 days [SD 8-197]), where VLBW neonates accounted
for only about 30%, with a median gestational age of 25 weeks. In
the cited study, the median LOS for all neonates was 30 days
(similar to the median LOS of VLBW neonates without infection in
Polish NICUs) and 76 days for VLBW neonates. The differences in
LOS seen in both studies may be due to different neonate
populations included in the trials. In the US study, only neonates
who required MV were eligible for inclusion, whereas in the Polish
study, MV was used in a small percentage of neonates (utilization
ratio: 0.25).
In a study by Payne et al.30 conducted in 17 US hospitals that
evaluated costs and prolonged LOS for VLBW infants with BSI, the
mean LOS of neonates with BSI ranged from 48 to 101 days
(depending on birth weight), compared with a mean LOS of 32 to
85 days for neonates without infections. The mean prolongation of
LOS secondary to BSI was, therefore, recorded at the level from
13 to 17 days – the upper limit of this range is thus approximate to
the result from Polish NICUs, i.e., the median prolongation of LOS
by 18 days in neonates with BSI. The analysis of data by
multivariate logistic regression demonstrated, however, an in-
crease in LOS for VLBW neonates with BSI by 4 to 7 days and
associated costs falling within the range from 5,875 USD to 12,480
USD. In contrast, Polish LOS values were similar to the results
obtained in a German study (NeoKISS) by Denkel et al.31
Despite nearly 20 years of experience with modern infection
control in Poland and the organisation of surveillance according to
international standards,32 there are virtually no studies concerning
the cost of infections. And reports of this type, for both adults and
neonates, are limited because of the socio-economic conditions
and healthcare organizations in Poland.
An attempt to estimate the costs of NICU care for premature
infants was undertaken by Krawczyk-Wyrwicka, who analysed
costs in one NICU,33,34 particularly the costs associated with BSI.
Table 3
Independent predictor of LOS of VLBW newborns, who were discharged from the
ward (without neonates who died or were transferred)
P value Lower 95% CI Upper 95% CI
birth weight <,001 -0.0495 -0.041
gestational age <,001 -0.203 -0.883
female sex 0.7 -0,550 0.777
CC 0.6 -4.605 8.329
CRIB <,001 0.100 0.687
Apgar 1 0.3 -0.920 0.281
Apgar 5 0.6 -0.435 0.732
choriamnionitis 0.9 -0.936 1.131
PROM 0.8 -0.948 0.696
not less than 1 infection <,001 -3.074 -1.462
adjusted for birth weight; gestational age; Clinical Risk Index for Babies, CRIB; score,
Apgar 1- and 5-minute scores, type of birth, gender, chorioamnionitis, PROM and at
least 1 infection.
OR odds ratio; CI confidence interval;
CC Caesarean section; CRIB Critical Risk Index for Babies; LOS length of stay; PROM
premature rupture of membranes; VLBW very low birth weight.
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hospitalization in an NICU ranged from 608 to 822 PLN (203 to
274 USD), and the cost per person-day of hospitalization for a
neonate with BSI was 2,152 PLN (717 USD). Linking the results
obtained in our study concerning the median prolonged LOS of
VLBW neonates with BSI and the cost per person-day established
by Krawczyk-Wyrwicka, allowed for the estimation of the cost of
prolonged LOS in Poland at 12,806 USD; that is, at the upper limit of
costs determined by Payne et al.,30 taking into account multivari-
ate logistic regression, and thus of extension of a shorter stay by
about one-third than established in this study.
Rosenthal et al. reported values for prolonged LOS in NICUs
similar to those obtained in our present study; for CLABSIs at
18.4 days and for VAP at 25.6 days (based on data from the
International Nosocomial Infection Control Consortium and
NHSN), but without a cost analysis.5 Rosenthal et al. also reported
a pooled crude mortality rate (undefined) for neonates without
infection, at 12.5% and ranging within the limits from 15.2% to
25.3% among neonates with infections. The in-hospital mortality
rate of VLBW neonates in our present study was 16.2%.
Analysis of the influence of infection, as conducted in this study,
on the LOS among VLBW neonates hospitalized in Polish NICUs
revealed a significant correlation between infection and this
outcome. However, in order to obtain a worthwhile assessment of
this correlation, it is necessary to also assess the general overall
condition of the neonate as expressed by such essential parameters
as birth weight, gestational age, and CRIB score, which, apart from
infection, may also substantially affect the LOS as well as in-
hospital mortality (Table 3). A significant correlation between CRIB
score, gestational age, and birth weight and the prognosis or
treatment outcomes has also been found in other studies [35,36]
5. Conclusions
The general overall condition of VLBW infants statistically
increases both mortality and LOS, in contrast to infection, which
significantly prolonged only the LOS in the NICU.
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